Literature DB >> 33552643

Complete Labyrinthine Aplasia: A Unique Sign for Targeted Genetic Testing in Hearing Loss.

Meenakshi Lallar1, Veronica Arora1, Renu Saxena1, Ratna Dua Puri1, Ishwar Chander Verma1.   

Abstract

Complete labyrinthine aplasia (CLA) is a rare inner ear anomaly. The only identified genetic cause of CLA with severe sensorineural hearing loss is labyrinthine aplasia, microtia, and microdontia (LAMM) syndrome. Here we reported a child who presented with syndromic hearing loss and was diagnosed with LAMM syndrome. Genetic evaluation provided the family with confirmation of the diagnosis, provision of the prognosis, genetic counselling, and prenatal diagnosis. This report highlighted that CLA should be recognized as a unique sign to diagnose LAMM syndrome, to analyze FGF3 gene mutation, and also demonstrated the utility of genetic testing in patients with suspected LAMM syndrome to provide exact diagnosis and further management. Thieme. All rights reserved.

Entities:  

Keywords:  FGF3 gene ; LAMM; complete labyrinthine aplasia

Year:  2020        PMID: 33552643      PMCID: PMC7853916          DOI: 10.1055/s-0040-1708052

Source DB:  PubMed          Journal:  J Pediatr Genet        ISSN: 2146-460X


  10 in total

1.  Three familial cases of Michel's aplasia.

Authors:  Ahmad Daneshi; Mohammad Farhadi; Alimohamad Asghari; Hesamedin Emamjomeh; Parvaneh Abbasalipour; Saeed Hasanzadeh
Journal:  Otol Neurotol       Date:  2002-05       Impact factor: 2.311

2.  THALIDOMIDE-INDUCED APLASIA OF THE INNER EAR.

Authors:  M B JORGENSEN; H K KRISTENSEN; N H BUCH
Journal:  J Laryngol Otol       Date:  1964-12       Impact factor: 1.469

Review 3.  Congenital hearing loss.

Authors:  Anna M H Korver; Richard J H Smith; Guy Van Camp; Mark R Schleiss; Maria A K Bitner-Glindzicz; Lawrence R Lustig; Shin-Ichi Usami; An N Boudewyns
Journal:  Nat Rev Dis Primers       Date:  2017-01-12       Impact factor: 52.329

4.  LAMM syndrome with middle ear dysplasia associated with compound heterozygosity for FGF3 mutations.

Authors:  Alberto Sensi; Stefano Ceruti; Patrizia Trevisi; Francesca Gualandi; Micol Busi; Ilaria Donati; Marcella Neri; Alessandra Ferlini; Alessandro Martini
Journal:  Am J Med Genet A       Date:  2011-04-07       Impact factor: 2.802

5.  Delayed presentation of rickets in a child with labyrinthine aplasia, microtia and microdontia (LAMM) syndrome.

Authors:  Ankur Singh; Mustafa Tekin; Michelle Falcone; Seema Kapoor
Journal:  Indian Pediatr       Date:  2014-11       Impact factor: 1.411

6.  Homozygous mutations in fibroblast growth factor 3 are associated with a new form of syndromic deafness characterized by inner ear agenesis, microtia, and microdontia.

Authors:  Mustafa Tekin; Burcu Oztürk Hişmi; Suat Fitoz; Hilal Ozdağ; Filiz Başak Cengiz; Asli Sirmaci; Idil Aslan; Bora Inceoğlu; E Berrin Yüksel-Konuk; Seda Taşir Yilmaz; Oztan Yasun; Nejat Akar
Journal:  Am J Hum Genet       Date:  2006-12-27       Impact factor: 11.025

Review 7.  Complete labyrinthine aplasia: clinical and radiologic findings with review of the literature.

Authors:  B Ozgen; K K Oguz; A Atas; L Sennaroglu
Journal:  AJNR Am J Neuroradiol       Date:  2009-01-15       Impact factor: 3.825

Review 8.  Genetics of hearing and deafness.

Authors:  Simon Angeli; Xi Lin; Xue Zhong Liu
Journal:  Anat Rec (Hoboken)       Date:  2012-10-08       Impact factor: 2.064

9.  Syndromic congenital sensorineural deafness, microtia and microdontia resulting from a novel homoallelic mutation in fibroblast growth factor 3 (FGF3).

Authors:  Osama Alsmadi; Brian F Meyer; Fowzan Alkuraya; Salma Wakil; Fadi Alkayal; Haya Al-Saud; Khushnooda Ramzan; MoeenAldeen Al-Sayed
Journal:  Eur J Hum Genet       Date:  2008-08-13       Impact factor: 4.246

10.  Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Authors:  Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm
Journal:  Genet Med       Date:  2015-03-05       Impact factor: 8.822

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.